AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2017
Mar 2, 2017
29875_dirs_2017-03-02_a27eb63b-e919-4fb5-99ef-38cbe7bcd95f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2017-02-28
Reporting Person: Kraft Robert O. (EVP and President - Omnicare)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-28 | Common Stock | A | 3809 | $80.58 | Acquired | 11222.1892 | Direct |
| 2017-02-28 | Common Stock | F | 1256 | $80.58 | Disposed | 9966.1892 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (pep) | 5661.1892 | Direct |
| Common Stock (restricted) | 87236 | Direct |
Footnotes
F1: Consists of stock awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.
F2: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3